Login
Home
Online Store
Membership benefits
Renewal Steps
Membership FAQs
Contact Information
My Professional Dev
My Events
Upcoming Events
Committees Leadership
Organization Directory
Articles
Donate Funds
Article Details



Newsletter

Epidemiology of Insomnia

Leger, Damien, 5/1/2007


Epidemiology of Insomnia

 

 

Damien Leger, MD, Ph D,

 

Head of Sleep and Vigilance Center, Rare Hypersomnia Reference Center.

Hotel Dieu de Paris, Assistance Publique Hopitaux de Paris and University of Paris 5 , School of Medicine, Paris, France.

 

 

Corresponding author:                    

Damien Leger, MD, Ph. D.                       

Centre du Sommeil et de la Vigilance

Hotel Dieu de Paris                            

1 pl. du Parvis Notre Dame                     

75181 PARIS CEDEX 04                     

Phone: 33 1 42 34 82 43                        

Fax: 33 1 42 34 82 27                          

Email: damien.leger@htd.aphp.fr          

 

 

 

 

 

 

Introduction

Insomnia is a very common complaint among the general population of adults around the world [1,2]. Despite this high prevalence, insomnia is however still unrecognized  by health professionals. One issue stands in the fact that insomnia is frequently considered as a symptom rather than as a true disease and is not clear for practitioners if it could be a symptom and a disease. Another difficulty is that it is often difficult for patients and for health professionals to understand when insomnia is severe enough to need a treatment. Then there is still insufficient knowledge about the management of insomnia. In the last decade several consensus meetings about insomnia, its recognition, diagnosis and treatment have been made [3-8], all these consensus groups have underlined the impact of insomnia on public health and the need to better encompass the consequences of insomnia on work, economics and quality of life. There is however very few international data comparing insomnia in the population of different countries around the planet.

The aim of this contribution is describe carefully the epidemiological issues of insomnia and its public health consequences and to point out what are the certitudes and the missing data we need for a better comprehension of the impact of insomnia in the daily lives of patients.

 

 

Epidemiology: magnitude of insomnia.

 

-     Epidemiology and definition.

Insomnia has to be clearly defined if we want to accurately know its prevalence in the general population. The first surveys have inquired about sleep disorders in the life time and they have found as much as 90% of subjects complaining of poor sleep [9]. These data are confusing and more recently the DSM-IV or ICSD definitions of insomnia have been more largely applied in epidemiological settings. Several large samples have been studied in the last decade. In 2002, Ohayon and Smirne  [10] conducted a study with a representative sample of the United Kingdom population of 3970 individuals aged 15 years or older: insomnia symptoms were reported by 27.6% of the sample. Sleep dissatisfaction was found in 10.1% and insomnia disorder diagnoses in 7% of the sample. The use of sleep-enhancing medication was reported by 5.7%. Leger et al. epidemiological questionnaire survey of a representative sample of the French population that included 12 778 individuals found a prevalence of insomnia of 19% with 9% presenting severe insomnia (at least two symptoms of insomnia according to the DSM-IV definition) [11]. Kim et al. found a prevalence of 21.4 % of insomniacs in a 3000 sample representative of the general population of Japan [12]. In the United States, the most recent study has been made by the National Sleep Foundation on a representative sample of 1506 subjects over 18 years old in 2004. 21% of the sample complained of insomnia according to the ICSD definition, but only 9% had insomnia and daytime consequences [13]. A compilation of the recent studies have been made by Ohayon in 2002 and assessed that insomnia usually concern around one adult on three in the general population [1]. However from 16 to 21% only have insomnia at least three times a week, from 13 to 17% qualify their trouble as important or major and 9 to 13% have insomnia and daytime consequences. To our knowledge, there is still no epidemiological study using the new research criteria [8]. 

 

-     Socio demographics

Almost all studies show an increasing prevalence of insomnia with age and a sex ratio in favor of women [1-7]. In a 12 778 sample, Leger et al found that severe insomnia was almost twice as high for women as for men (12% vs. 6.3%; p < 0.0001) [11]. Older subjects have usually more severe complaints than younger. In a representative sample (n = 5 622) of the general population of France aged 15 or older, Ohayon and Lemoine found that the prevalence of insomnia was twice more frequent in subjects 65 years of age or older compared to subjects younger than 45 years [13].  Moreover, in this last study, 47.1% of subjects above 65 years reported three symptoms of insomnia compared to 32.2% of subjects under 44 tears old (p <0.001). However younger subjects (under 45 years) and females had significantly more daytime consequences of insomnia than older and males.

There are few studies trying to support the link between perceived job stress and the prevalence of insomnia except the study made by Nakata et al in 1161 male white-collar employee of a Japanese electric equipment company surveyed by a mailed questionnaire [14]. This study found an overall prevalence rate of insomnia of 23.6%  Workers with high intragroup conflict (OR 1.6), high job dissatisfaction (OR 1.5) had a significantly increased risk of insomnia after adjusting for multiple confounding factors. Low employment opportunities, physical environment and low coworker support also were weakly associated with a risk of insomnia among workers.

Insomnia is also generally higher in persons with low socio-economical status [15]. In the French population, the prevalence of insomnia was the highest in the white collar group (20, 8%) [11]. It was also found a trend towards lower rates of insomnia in upper level executives, liberal professions and in farmers group. Doi et al, in a cross sectional study including 4868 day time white-collar workers similarly showed that poor sleep was significantly more prevalent in white collars (30 to 45 %) than in  the Japanese general working population [16]. Recently, Gellis et al, have investigated the likelihood of insomnia and insomnia-related health consequences among  a sample of at least 50 men and 50 women in each age decade from 20 to 80+ years old and of different socioeconomic status [17].  Results indicated that individuals of lower individual and household education were significantly more likely to experience insomnia, even after researchers accounted for ethnicity, gender, and age. Additionally, individuals with fewer years of education, particularly those who had dropped out of high school, experienced greater subjective impairment because of their insomnia.

 

-     Seeking help and access to the treatments

 

Insomniacs and even severe insomniacs are not always seeking help for treatment. Years ago, the Gallup study found that only 5% of insomniacs had ever visited a physician to dis¬cuss specifically their sleeping problem and that only 21% had ever taken a prescription medication for sleep  [9].  In France 53% of severe insomniacs vs. 27% of subjects with occasional sleep problems reported they had ever visited a doctor specifically for insomnia (p<10 4) [18]. A lot of persons with sleep dissatisfaction are just watching television, reading, using non prescription medication, or drinking alcohol to promote sleep [1]. In a survey in the Detroit area of a rep¬resentative sample of 2,181 adults aged 18 45, Johnson et al. found that 13.3% used alcohol as a sleep aid in the past year and 10.1% an over the counter prescription [19]. Fifteen percent of those who used alcohol as a sleep aid did it for at least one month; however the duration of use was short for the majority of users (less than one week). Only 5.3% used a prescription medication. However, 10.8% of French adults regularly used prescription medication to promote sleep [20]. Recently a consecutive sample (n = 700) of adults attending a non-urgent primary care appointment was screened for sleep problems in the U.S. A follow-up mailed survey then assessed insomnia symptoms, daytime impairment, beliefs about sleep, medication use, sleepiness and fatigue, and medical help-seeking [21]. They conversely found that a high 52 % of patients with probable insomnia reported discussing this with a physician. Multivariate logistic regression analyses indicated that discussing one's probable insomnia with a physician was independently associated with having a greater number of medical conditions (OR, 2.19 [95% CI, 1.13 to 4.22]), being more highly educated (1.67 [95% CI, 1.11 to 2.51]), sleeping less per night (OR, 0.71 [95% CI, 0.52 to 0.96]), and greater perceived daytime impairment due to insomnia (OR, 2.07 [95% CI, 1.06 to 4.03]).

Diagnosis of insomnia is not always followed by treatment. In Germany, a Nationwide Insomnia Screening and Awareness Study (NISAS-2000) found that close to 50% of all patients with insomnia did not receive a prescription for a specific insomnia therapy [22].

 

-     Natural history

There are very few data on the natural history of insomnia. Severe insomnia seems to be more persistent than mild insomnia. Katz and Mc Horney have reassessed two years later a group of 3445 patients with insomnia: 83% of patients with severe insomnia remained so categorized, compared to 59% of patients with mild insomnia [23]. Hohagen et al. have also shown that 4 months after a first survey, 87% of patients who initially reported a sleep complaint still have a sleep complaint [24]. According to Mendelson et al., 88.2% of patients continue to report sleep problems five years after the onset [25].  Predisposing, precipitating and perpetuating factors contribute in the natural history of insomnia of subjects presenting variable vulnerability [26, 27].  In a recent study of  345 patients evaluated for insomnia at a sleep-disorders clinic in Quebec, Bastien et al have identified, the specific precipitating events related to the onset of insomnia. The most common precipitating factors of insomnia were related to family, health, and work-school events. Sixty-five percent of precipitating events had a negative valence. These events differed with the age of onset of insomnia but not with the gender of participants [28] .

-     Comorbidty with depression and anxiety

Insomnia is associated with a variety of medical and psychiatric conditions. It is usually more easy to clarify how insomnia is due to medical problems than to understand how insomnia is a cause or a consequence of psychiatric diseases. Comorbidities with depression and anxiety are estimated to occur in 35 to 60% of chronic insomniacs  [1, 4-7,27,29-30].  Several longitudinal studies have shown that insomnia may represent a substantial and statistical risk for the development of depressive disorders  [31-33]. However, there is actually an increasing support to believe that the coexistence of these two disease reflect a common pathology rather than two separate diseases. In order to clarify public health consequences due to insomnia by itself, it seems however important to clearly identify insomniacs with psychiatric diseases in the design of the studies.

 

Daytime consequences

 

Even though there is broad consensus on the fact that daytime impact is a major criterion in the definition of insomnia [7-9], the precise nature of this impact remains subject to debate. In a review of insomnia and daytime functioning, Riedel and Lichstein suggested that the lack of objective findings in the literature might be explained by (a) a focus on variables that are not impaired (rather than areas of actual impairment) and (b) methodological problems (such as non-homogeneous groups of subjects) which may have hidden actual differences between insomniacs and good sleepers [34]. Daytime sleepiness has received the most attention but it is becoming clear that a large number of insomniacs are not sleepy during the day [35-36]. Bonnet and col. have even used MSLTs to demonstrate that insomniacs were more alert in the daytime than good sleepers [36].  However, the absence of an objective somnolence deficit does not mean that insomniacs are not impaired during the daytime.

 

Riedel and Lichstein also recommended using objective measures of work performance (absenteeism, promotion, etc.) to clarify the impact of insomnia on daytime functioning [34]. Insomnia is not a visible handicap in the workplace and it is difficult for insomniacs to explain to their colleagues and managers that they have had a poor night and that they need to rest… Insomniacs have to face a regular work load and they often complain of difficulties in their professional life [25, 37-38].  However, there are few data assessing the true impact of insomnia on daily work. This is a crucial point to try to evaluate the impact of insomnia on absenteeism and other work measures in a real setting.

 

 

Conclusion: Education

Millions of people are suffering of insomnia around the world. In addition to its nocturnal effect insomnia affects deeply the daily lives of patients. The economic impact of insomnia on the collectivity seems enormous. There is also an increasing evidence linking insomnia to several severe public health concerns: obesity, diabetis, depression, cardio-vascular diseases.

There is a major need for education of doctors and information of the general public about sleep, insomnia and the management of this disorder;

 

References

 

1.    Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97-111.

2.    Soldatos CR, Allaert FA, Ohta T, Dikeos DG. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Medicine 2005;6:5-13.

3.    Roth T, Hajak G, and Ustun TB. Consensus for the pharmacological management of insomnia in the new millenium. Int J Clin Pract 2001;55:42-52.

4.    World Health Organization. Insomnia: an international consensus conference report. Versailles, 13-15 october 1996. WHO Publications MSA/MDN/98.2, 1998:55 p.

5.    Buysse DJ. Diagnosis and assessment of sleep and circadian rhythm disorders. J Psychiatr Pract. 2005;11:102-15.

6.    Kupfer DJ and Reynolds CF. Management of insomnia. N Eng J Med 1997;336:341-346.

7.    Schenck CH, Mahowald MW, Sack RL. Assessment and management of insomnia. JAMA 2003;19:2475-9.

8.    Edinger JD, Bonnet MH, Bootzin RR, Doghramji K, Dorsey CM, Espie CA, Jamieson AO, McCall WV, Morin CM, Stepanski EJ; American Academy of Sleep Medicine Work Group. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep. 2004;27:1567-96.

9.    National Sleep Foundation (NSF). Sleep in America. Gallup Organization. Princeton, NJ, 1991.

10.   Ohayon MM, Smirne S. Prevalence and consequences of insomnia disorders in the general population of Italy. Sleep Med. 2002;3:115-20.

11.   Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res. 2000;9:35-42.

12.   Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep. 2000;23: 41-7.

13.   Ohayon MM, Lemoine P. Daytime consequences of insomnia complaints in the French general population. L'Encephale, 2004; XXX: 222-7.

14.   Nakata A, Haratani T, Takahashi M, Kawakami N, Arito H, Kobayashi F, Araki S. Job stress, social support, and prevalence of insomnia in a population of Japanese daytime workers. Social Science & Medicine 2004;59:1719-1730.

15.   Walsh JK. Clinical and Socioeconomic Correlates of Insomnia. J Clin Psychiatry 2004; 65  (suppl 8): 13-19.

16.   Doi Y, Minowa M, Tango T. Impact and correlates of poor sleep quality in Japanese white- collar employees. Sleep 2003 ; 26: 467-71.

17.   Gellis LA, Lichstein KL, Scarinci IC, Durrence HH, Taylor DJ, Bush AJ, Riedel BW. Socioeconomic status and insomnia. J Abnorm Psychol. 2005;114:111-8.

18.   Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep. 2002;25:625-9.

19.   Johnson EO, Roehrs T, Roth T, Breslau N. Epidemiology of alcohol and medication as aid sleep in early adulthood. Sleep 1998;21:178-86.

20.   Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999;22 (suppl 2):5394 -5401.

21.   Aikens JE, Rouse ME. Help-seeking for insomnia among adult patients in primary care. J Am Board Fam Pract. 2005;18:257-61.

22.   Wittchen HU, Krause P, Hofler M, Pittrow D, Winter S, Spiegel B, Hajak G, Riemann D, Steiger A, Pfister H. NISAS-2000: The "Nationwide Insomnia Screening and Awareness Study". Prevalence and interventions in primary care. Fortschr Med Orig. 2001;119:9-19.

23.   Katz DA, Mc-Horney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;159:1099-107.

24.   Hohagen F, Kappler C, Schramm E, Riemann D, Weyeser S, Berger M. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening-temporal stability of subtypes to a longitudinal study on general practice attendees. Sleep 1994;17-551-4.

25.   Mendelson WB, Garnett D, Linnoila M. Do insomniacs have impaired daytime functioning? Biol Psy 1984;1261-3.

26.   Drake C, Richardson G, Roehrs T, Scofield H, Roth T. Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep 2004;27:285-91.

27.   Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depression and Anxiety 2003;18:163-176.

28.   Bastien CH, Vallieres A, Morin CM.Precipitating factors of insomnia. Behav Sleep Med. 2004;2:50-62.

29.   Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry. 1997;171:382-8.

30.   Hohagen F, Rink K, Kappler C, Schramm E, Riemann D, Weyerer S, Berger M. Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci. 1993;242:329-36.

31.   Ford DE, Kamerow DB. Epidemiological study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-1484.

32.   Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The John Hopkins Precursors Study. Am J Epidemiol 1997 ;146:105-114.

33.   Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002;51:229-35.

34.   Riedel BW and Lichstein KL. Insomnia and daytime functioning. Sleep Medicine Reviews 2000; 4:277-98.

35.   Stepanski E, Zorick F, Roehrs T, et al.  Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep1988;11:54 60.

36.   Bonnet MH, Arand DL. Activity, arousal, and the MSLT in patients with insomnia. Sleep 2000; 23:205-212.

37.   Schneider-Helmert D. Twenty four hour sleep/wake function and personality patterns in chronic insomniacs and healthy controls. Sleep 1987;11:54-60.

38.   Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Quality of Life Research 2001;10:331-45.


 

World Sleep Society is located in the United States.

To request a refund, contact info@worldsleepsociety.org within 30 days of purchase. Refund requests received after 30 days, will be reviewed on a case-by-case basis.

Merchant cards accepted: VISA, MasterCard, American Express, Discover Card

Privacy Policy | Terms and Use 
© Copyright 2018-2019 World Sleep Society.  All Rights Reserved.



© 2020 Community Brands Holdings, LLC. All rights reserved.